focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOctopus Aim 2 Regulatory News (OSEC)

Share Price Information for Octopus Aim 2 (OSEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: -1.00 (-2.04%)
Spread: 2.00 (4.255%)
Open: 49.00
High: 49.00
Low: 48.00
Prev. Close: 49.00
OSEC Live PriceLast checked at -
Octopus AIM VCT 2 is an Investment Trust

To provide shareholders with attractive tax-free dividends and long-term capital growth by investing in a diverse portfolio of predominantly AIM-traded companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

20 Oct 2008 08:54

RNS Number : 1900G
Octopus IHT AIM VCT PLC
20 October 2008
 



Octopus (formerly CloseIHT AIM VCT plc ("Company" or "Fund")

20 October 2008

Interim Management Statement 

For the period from 1 June 2008 to 15 October 2008

In accordance with Rule 4.3 of the UK Listing Authority's Disclosure and Transparency rules, Octopus IHT AIM VCT plc presents an Interim Management Statement for the period 1 June 2008 to 15 October 2008, being the latest weekly valuation prior to the date of this statement.

Change of Manager

Shareholders will be aware that in the period covered by this report there has been a change to the corporate identity of the Company. Following the move by Andrew Buchanan and Kate Tidbury from Close investments Limited to Octopus Investments Limited, your Board agreed to novate the Management Agreement to Octopus Investments. As a result it was necessary to change the name of your Company which was approved at a General Meeting at the beginning of September. Shareholders existing share certificates have not been replaced and remain valid.

Financial Highlights 

As at 15 October 2008 

As at 30

September 2008

As at 31 

May 2008

As at 30 

November 2007

Net assets ('000)

£16,884

£17,929

£21,613

£23,518

Net asset value per share ("NAV")

67.6p

71.8p

86.5p

94.2p

Cumulative dividends paid since launch

5.4p

4.4p

4.4p

3.4p

Total return (NAV plus dividends paid)

73.0p

76.2p

90.9p

97.6p

Share price 

73.0p

73.0p

88.0p

94.0p

Premium/(discount) to NAV 

(8.0)%

1.7%

1.7%

(0.2)%

Investment Performance and Activity

Investors have faced a difficult time in the period covered by this report with significant turmoil in the stock market caused by the hiatus in the banking sector. The consequence has been a further reduction in share prices, most particularly amongst smaller companies, such as those this Venture Capital Trust ("VCT") invests in.  The total return, as a result, has fallen by 19.7between 1 May and 15 October. For the sake of comparison the FTSE AIM All Share Index has fallen by 53.5% between 1 June and 15 October and the FTSE SmallCap index by 31.9% in the same period.

Despite this market background not being conducive to flotations and further issues of new shares, this VCT has managed to make three new qualifying investments, totalling £2.1m. As at 15 October the fund is 65% invested in qualifying investments. It has until 30 November 2008 to reach the minimum 70% level required by HMRC regulations. With the current pipeline of opportunities your manager is confident of achieving this level. Following the change of manager outlined above, the reduction in the Close Special Situations Fund was accelerated and the final shares were sold in the period under review.

The total value of the AIM quoted investment portfolio at 15 October was £9.5m. These figures exclude cash holdings and are at bid prices.  

Ten largest holdings by value as at 15 October 2008

Company

Carrying value £'000

Percentage 

onet assets

IS Pharma 

753

4.6%

Research Now 

663

3.9%

Animalcare Group 

654

3.8%

Advanced Computer Software

618

3.7%

Pressure Technologies

577

3.4%

Tasty

550

3.3%

Essentaily

527

3.1%

Mount Engineering plc

499

3.0%

Clerkenwell Ventures plc

468

2.8%

Neuropharm plc

442

2.6%

Dividends 

As stated in the interim report for the 6 months ended 31 May 2008, a dividend of 1.0p per 'A' and 'B' Ordinary share was declared and this was paid to shareholders on 10 October 2008.

Buybacks 

During the period the Fund bought back 15,250 'A' Ordinary shares at a price of 70p per share. These are currently held in Treasury.

Total voting rights and capital

At the date of this announcement, the capital of the Company consists of 7,299,461 'A' Ordinary shares and 17,680,650 'B' Ordinary shares with a nominal value of 0.01 pence each, with voting rights. Octopus IHT AIM VCT plc holds 15,250 'A' Ordinary Shares in Treasury.

Therefore, the total number of voting rights in the Company plc is 24,964,861.

The figure of 24,964,861 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Octopus IHT AIM VCT plc under the FSA's Disclosure and Transparency Rules.

Material events and transactions

The Board is not aware of any further material events or transactions between 15 October 2008 and the date of this report.

For further information please contact:

Andrew Buchanan/Kate Tidbury

Octopus Investments Limited 

Tel: 020 7710 2800

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKGMZGNGMGRZG
Date   Source Headline
15th May 202411:00 amGNWNet Asset Value(s)
8th May 20245:50 pmGNWNet Asset Value(s)
8th May 20245:45 pmGNWNet Asset Value(s)
1st May 20247:00 amGNWTotal Voting Rights and Capital
30th Apr 20244:40 pmGNWNet Asset Value(s)
25th Apr 20244:05 pmGNWPurchase of Own Securities and Total Voting Rights
24th Apr 202412:15 pmGNWNet Asset Value(s)
17th Apr 20241:10 pmGNWNet Asset Value(s)
12th Apr 202410:40 amGNWNet Asset Value(s)
10th Apr 20243:30 pmGNWNet Asset Value(s)
10th Apr 20243:25 pmGNWNet Asset Value(s)
2nd Apr 20247:00 amGNWTotal Voting Rights and Capital
27th Mar 20242:16 pmGNWNet Asset Value(s)
26th Mar 20243:40 pmGNWAnnual Report for the year ended 30 November 2023 and Notice of Meeting
21st Mar 20245:00 pmGNWPurchase of Own Securities and Total Voting Rights
19th Mar 20245:25 pmGNWNet Asset Value(s)
14th Mar 20249:45 amGNWNet Asset Value(s)
14th Mar 20249:40 amGNWNet Asset Value(s)
14th Mar 20249:35 amGNWNet Asset Value(s)
8th Mar 20247:00 amGNWFinal Results
1st Mar 202410:05 amGNWNet Asset Value(s)
1st Mar 20247:00 amGNWTotal Voting Rights and Capital
22nd Feb 20244:30 pmGNWPurchase of Own Securities and Total Voting Rights
20th Feb 20244:40 pmGNWNet Asset Value(s)
15th Feb 20245:35 pmGNWNet Asset Value(s)
7th Feb 20245:25 pmGNWNet Asset Value(s)
7th Feb 20245:20 pmGNWNet Asset Value(s)
1st Feb 20247:00 amGNWTotal Voting Rights and Capital
31st Jan 20249:25 amGNWNet Asset Value(s)
24th Jan 202411:05 amGNWNet Asset Value(s)
18th Jan 20246:00 pmGNWPurchase of Own Securities and Total Voting Rights
17th Jan 20242:45 pmGNWNet Asset Value(s)
12th Jan 20249:30 amGNWIssue of Equity and Total Voting Rights
10th Jan 202411:30 amGNWNet Asset Value(s)
8th Jan 20246:35 pmGNWNet Asset Value(s)
8th Jan 20246:30 pmGNWNet Asset Value(s)
2nd Jan 20247:00 amGNWTotal Voting Rights and Capital
29th Dec 20234:00 pmGNWDirector Appointment
28th Dec 20235:45 pmGNWNet Asset Value(s)
21st Dec 20235:00 pmGNWClose of Offers to Further Applications
21st Dec 20238:20 amGNWNet Asset Value(s)
15th Dec 20239:25 amGNWIssue of Equity and Total Voting Rights
14th Dec 20234:10 pmGNWPurchase of Own Securities and Total Voting Rights
12th Dec 20234:05 pmGNWNet Asset Value(s)
8th Dec 20233:45 pmGNWNet Asset Value(s)
6th Dec 20232:15 pmGNWNet Asset Value(s)
1st Dec 20237:00 amGNWTotal Voting Rights and Capital
29th Nov 202311:40 amGNWNet Asset Value(s)
21st Nov 20234:15 pmGNWNet Asset Value(s)
17th Nov 20237:00 amGNWPurchase of Own Securities and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.